Apellis Pharmaceuticals, Inc.
pegcetacoplan
geographic atrophy (GA)
Date
TBD
Approval decision · Date TBD estimated
What's at stake
A final FDA approval decision on pegcetacoplan for geographic atrophy (GA) is expected Date TBD.
Primary source
· SEC 8-K
verified 16h ago
“EMPAVELI is also approved for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) in the United States, European Union, and other countries globally.”